Cargando…

Comprehensive of N1-Methyladenosine Modifications Patterns and Immunological Characteristics in Ovarian Cancer

BACKGROUND: recently, many researches have concentrated on the relevance between N1-methyladenosine (m1A) methylation modifications and tumor progression and prognosis. However, it remains unknown whether m1A modification has an effect in the prognosis of ovarian cancer (OC) and its immune infiltrat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Jinhui, Chen, Can, Wang, Yichun, Qian, Cheng, Wei, Junting, Xing, Yan, Bai, Jianling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8588846/ https://www.ncbi.nlm.nih.gov/pubmed/34777359 http://dx.doi.org/10.3389/fimmu.2021.746647

Ejemplares similares

Construction of an Immune Cell Infiltration Score to Evaluate the Prognosis and Therapeutic Efficacy of Ovarian Cancer Patients
por: Liu, Jinhui, et al.
Publicado: (2021)

RNA N1-methyladenosine regulator-mediated methylation modification patterns and heterogeneous signatures in glioma
por: Mao, Meng, et al.
Publicado: (2022)

Comprehensive Analysis of N6-methyladenosine Modification Patterns Associated With Multiomic Characteristics of Bladder Cancer
por: Liu, Jingchao, et al.
Publicado: (2021)

N(6) -Methyladenosine and Rheumatoid Arthritis: A Comprehensive Review
por: Wu, Sha, et al.
Publicado: (2021)

The Non-N(6)-Methyladenosine Epitranscriptome Patterns and Characteristics of Tumor Microenvironment Infiltration and Mesenchymal Transition in Glioblastoma
por: Xu, Jianye, et al.
Publicado: (2022)

Crosstalk of RNA Adenosine Modification-Related Subtypes, Establishment of a Prognostic Model, and Immune Infiltration Characteristics in Ovarian Cancer
por: Ni, Xiaoge, et al.
Publicado: (2022)

Landscape of N(6)-Methyladenosine Modification Patterns in Human Ameloblastoma
por: Niu, Xing, et al.
Publicado: (2020)

N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy
por: Guo, Liting, et al.
Publicado: (2021)

Distribution Patterns of DNA N6-Methyladenosine Modification in Non-coding RNA Genes
por: Li, Yu, et al.
Publicado: (2020)

Emerging Perspectives of RNA N(6)-methyladenosine (m(6)A) Modification on Immunity and Autoimmune Diseases
por: Tang, Lipeng, et al.
Publicado: (2021)

Immunological modifications following chemotherapy are associated with delayed recurrence of ovarian cancer
por: Adzibolosu, Nicholas, et al.
Publicado: (2023)

Corrigendum: Distribution Patterns of DNA N6-Methyladenosine Modification in Non-coding RNA Genes
por: Li, Yu, et al.
Publicado: (2020)

Computed Tomography Imaging-Based Radiogenomics Analysis Reveals Hypoxia Patterns and Immunological Characteristics in Ovarian Cancer
por: Feng, Songwei, et al.
Publicado: (2022)

Comprehensive analysis of lncRNAs N(6)-methyladenosine modification in colorectal cancer
por: Zuo, Luo, et al.
Publicado: (2021)

N6-Methyladenosine Regulator-Mediated Immue Patterns and Tumor Microenvironment Infiltration Characterization in Glioblastoma
por: Xiong, Wu, et al.
Publicado: (2022)

N(6)-methyladenosine modification of viral RNA and its role during the recognition process of RIG-I-like receptors
por: Li, Huanan, et al.
Publicado: (2022)

The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer
por: Hu, Xiaoge, et al.
Publicado: (2022)

Comprehensive Analysis and Functional Characteristics of Differential Expression of N6-Methyladenosine Methylation Modification in the Whole Transcriptome of Rheumatoid Arthritis
por: Wan, Lei, et al.
Publicado: (2022)

N(6)-Methyladenosine in Cancer Immunotherapy: An Undervalued Therapeutic Target
por: Quan, Chao, et al.
Publicado: (2021)

Function of N6-Methyladenosine Modification in Tumors
por: Zhang, Nan, et al.
Publicado: (2021)

Role of N6-methyladenosine RNA modification in gastric cancer
por: Ding, Si-Qi, et al.
Publicado: (2023)

One Stone, Two Birds: N6-Methyladenosine RNA Modification in Leukemia Stem Cells and the Tumor Immune Microenvironment in Acute Myeloid Leukemia
por: Ouyang, Xianfeng, et al.
Publicado: (2022)

N1-Methyladenosine-Related lncRNAs Are Potential Biomarkers for Predicting Prognosis and Immune Response in Uterine Corpus Endometrial Carcinoma
por: Liu, Jinhui, et al.
Publicado: (2022)

N6-Methyladenosine Modification Patterns and Tumor Microenvironment Immune Characteristics Associated With Clinical Prognosis Analysis in Stomach Adenocarcinoma
por: Meijing, Zhang, et al.
Publicado: (2022)

Necroptosis-Related Modification Patterns Depict the Tumor Microenvironment, Redox Stress Landscape, and Prognosis of Ovarian Cancer
por: Geng, Rui, et al.
Publicado: (2023)

METTL3-Mediated N6-Methyladenosine Modification of Trim59 mRNA Protects Against Sepsis-Induced Acute Respiratory Distress Syndrome
por: Chen, Yi, et al.
Publicado: (2022)

Analysis of N6-Methyladenosine Modification Patterns and Tumor Immune Microenvironment in Pancreatic Adenocarcinoma
por: Liu, Yong, et al.
Publicado: (2022)

N6-methyladenosine methylation modification patterns reveal immune profiling in pancreatic adenocarcinoma
por: Xu, Hao, et al.
Publicado: (2022)

Detection of N(6)-methyladenosine modification residues (Review)
por: Zhu, Wei, et al.
Publicado: (2019)

Evolution of transcript modification by N(6)-methyladenosine in primates
por: Ma, Lijia, et al.
Publicado: (2017)

Function and evolution of RNA N6-methyladenosine modification
por: Zhu, Zhi-Man, et al.
Publicado: (2020)

RNA N(6)-Methyladenosine Modifications and the Immune Response
por: Wang, Ya-Nan, et al.
Publicado: (2020)

The functions of N6-methyladenosine modification in lncRNAs
por: He, Rong-Zhang, et al.
Publicado: (2020)

Epigenetic regulation of N6‐methyladenosine modifications in obesity
por: Sun, Mingli, et al.
Publicado: (2021)

Role of N6-methyladenosine Modification in Cardiac Remodeling
por: Choy, ManTing, et al.
Publicado: (2022)

The Role of N(6)-Methyladenosine Modification in Microvascular Dysfunction
por: Zhang, Ye-Ran, et al.
Publicado: (2022)

Corrigendum to “Function of N6-Methyladenosine Modification in Tumors”
por: Zhang, Nan, et al.
Publicado: (2023)

The crucial roles of N(6)-methyladenosine (m(6)A) modification in the carcinogenesis and progression of colorectal cancer
por: Fang, Zhihao, et al.
Publicado: (2021)

Pyroptosis-related gene expression patterns and corresponding tumor microenvironment infiltration characterization in ovarian cancer
por: Liu, Jinhui, et al.
Publicado: (2022)

N(6)-Methyladenosine regulator RBM15B acts as an independent prognostic biomarker and its clinical significance in uveal melanoma
por: Wang, Tianyu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7dcbvfn1npc598e49aojtd51iu